|
1
|
Luo YX, Chen DK, Song SX, Wang L and Wang
JP: Aberrant methylation of genes in stool samples as diagnostic
biomarkers for colorectal cancer or adenomas: A meta-analysis. Int
J Clin Pract. 65:1313–1320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dashwood RH: Early detection and
prevention of colorectal cancer (Review). Oncol Rep. 6:277–281.
1999.PubMed/NCBI
|
|
4
|
Li J and Lee AS: Stress induction of
GRP78/BiP and its role in cancer. Curr Mol Med. 6:45–54. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Liu R, Ni M, Gill P and Lee AS:
Cell surface relocalization of the endoplasmic reticulum chaperone
and unfolded protein response regulator GRP78/BiP. J Biol Chem.
285:15065–15075. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rao RV, Peel A, Logvinova A, del Rio G,
Hermel E, Yokota T, Goldsmith PC, Ellerby LM, Ellerby HM and
Bredesen DE: Coupling endoplasmic reticulum stress to the cell
death program: Role of the ER chaperone GRP78. FEBS Lett.
514:122–128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takada K, Hirose J, Yamabe S, Uehara Y and
Mizuta H: Endoplasmic reticulum stress mediates nitric
oxide-induced chondrocyte apoptosis. Biomed Rep. 1:315–319.
2013.
|
|
8
|
Pyrko P, Schönthal AH, Hofman FM, Chen TC
and Lee AS: The unfolded protein response regulator GRP78/BiP as a
novel target for increasing chemosensitivity in malignant gliomas.
Cancer Res. 67:9809–9816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song MS, Park YK, Lee JH and Park K:
Induction of glucose-regulated protein 78 by chronic hypoxia in
human gastric tumor cells through a protein kinase
C-epsilon/ERK/AP-1 signaling cascade. Cancer Res. 61:8322–8330.
2001.PubMed/NCBI
|
|
10
|
Daneshmand S, Quek ML, Lin E, Lee C, Cote
RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, et al:
Glucose-regulated protein GRP78 is up-regulated in prostate cancer
and correlates with recurrence and survival. Hum Pathol.
38:1547–1552. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng HC, Takahashi H, Li XH, Hara T,
Masuda S, Guan YF and Takano Y: Overexpression of GRP78 and GRP94
are markers for aggressive behavior and poor prognosis in gastric
carcinomas. Hum Pathol. 39:1042–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baptista MZ, Sarian LO, Vassallo J, Pinto
GA, Soares FA and de Souza GA: Prognostic significance of GRP78
expression patterns in breast cancer patients receiving adjuvant
chemotherapy. Int J Biol Markers. 26:188–196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang LH, Yang XL, Zhang X, Cheng JX and
Zhang W: Association of elevated GRP78 expression with increased
astrocytoma malignancy via Akt and ERK pathways. Brain Res.
1371:23–31. 2011. View Article : Google Scholar
|
|
14
|
Lin JA, Fang SU, Su CL, Hsiao CJ, Chang
CC, Lin YF and Cheng CW: Silencing glucose-regulated protein 78
induced renal cell carcinoma cell line G1 cell-cycle arrest and
resistance to conventional chemotherapy. Urol Oncol.
32:29.e1–29.e11. 2014. View Article : Google Scholar
|
|
15
|
Xing X, Li Y, Liu H, Wang L and Sun L:
Glucose regulated protein 78 (GRP78) is overexpressed in colorectal
carcinoma and regulates colorectal carcinoma cell growth and
apoptosis. Acta Histochem. 113:777–782. 2011. View Article : Google Scholar
|
|
16
|
Li Z, Zhang L, Zhao Y, Li H, Xiao H, Fu R,
Zhao C, Wu H and Li Z: Cell-surface GRP78 facilitates colorectal
cancer cell migration and invasion. Int J Biochem Cell Biol.
45:987–994. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roller C and Maddalo D: The molecular
chaperone GRP78/BiP in the development of chemoresistance:
Mechanism and possible treatment. Front Pharmacol. 4:102013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Misra UK, Deedwania R and Pizzo SV:
Binding of activated alpha2-macroglobulin to its cell surface
receptor GRP78 in 1-LN prostate cancer cells regulates
PAK-2-dependent activation of LIMK. J Biol Chem. 280:26278–26286.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen M, Zhang Y, Yu VC, Chong YS, Yoshioka
T and Ge R: Isthmin targets cell-surface GRP78 and triggers
apoptosis via induction of mitochondrial dysfunction. Cell Death
Differ. 21:797–810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu R, Yang P, Wu HL, Li ZW and Li ZY:
GRP78 secreted by colon cancer cells facilitates cell proliferation
via PI3K/Akt signaling. Asian Pac J Cancer Prev. 15:7245–7249.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar
|
|
22
|
Roux PP and Blenis J: ERK and p38
MAPK-activated protein kinases: A family of protein kinases with
diverse biological functions. Microbiol Mol Biol Rev. 68:320–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fruman DA and Rommel C: PI3K and cancer:
Lessons, challenges and opportunities. Nat Rev Drug Discov.
13:140–156. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu Y, Wey S, Wang M, Ye R, Liao CP,
Roy-Burman P and Lee AS: Pten null prostate tumorigenesis and AKT
activation are blocked by targeted knockout of ER chaperone
GRP78/BiP in prostate epithelium. Proc Natl Acad Sci USA.
105:19444–19449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z and Li Z: Glucose regulated protein
78: A critical link between tumor microenvironment and cancer
hallmarks. Biochim Biophys Acta. 1826:13–22. 2012.PubMed/NCBI
|
|
26
|
Lee AS: GRP78 induction in cancer:
Therapeutic and prognostic implications. Cancer Res. 67:3496–3499.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra
SK, Krasnoperov V, Dong D, Liu S, Li D, et al: Monoclonal antibody
against cell surface GRP78 as a novel agent in suppressing PI3K/AKT
signaling, tumor growth, and metastasis. Clin Cancer Res.
19:6802–6811. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Misra UK, Deedwania R and Pizzo SV:
Activation and crosstalk between Akt, NF-kappaB, and unfolded
protein response signaling in 1-LN prostate cancer cells consequent
to ligation of cell surface-associated GRP78. J Biol Chem.
281:13694–13707. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kelber JA, Panopoulos AD, Shani G, Booker
EC, Belmonte JC, Vale WW and Gray PC: Blockade of Cripto binding to
cell surface GRP78 inhibits oncogenic Cripto signaling via
MAPK/PI3K and Smad2/3 pathways. Oncogene. 28:2324–2336. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang LJ, Chen S, Wu P, Hu CS, Thorne RF,
Luo CM, Hersey P and Zhang XD: Inhibition of MEK blocks GRP78
up-regulation and enhances apoptosis induced by ER stress in
gastric cancer cells. Cancer Lett. 274:40–46. 2009. View Article : Google Scholar
|
|
31
|
Feng C, He K, Zhang C, Su S, Li B, Li Y,
Duan CY, Chen S, Chen R, Liu Y, et al: JNK contributes to the
tumorigenic potential of human cholangiocarcinoma cells through the
mTOR pathway regulated GRP78 induction. PLoS One. 9:e903882014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gray MJ, Mhawech-Fauceglia P, Yoo E, Yang
W, Wu E, Lee AS and Lin YG: AKT inhibition mitigates GRP78
(glucose-regulated protein) expression and contribution to
chemoresistance in endometrial cancers. Int J Cancer. 133:21–30.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang YJ, Huang YP, Li ZL and Chen CH:
GRP78 knockdown enhances apoptosis via the down-regulation of
oxidative stress and Akt pathway after epirubicin treatment in
colon cancer DLD-1 cells. PLoS One. 7:e351232012. View Article : Google Scholar : PubMed/NCBI
|
